Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL)

NCT01037764 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
100
Enrollment
OTHER
Sponsor class

Stopped The PI resigned the institute, and the rest investigators at the institute decided to terminate the study.

Conditions

Interventions

Sponsor

Asan Medical Center